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ABSTRACT
The purpose of the present study was to investigate the effects of different dietary concentrations of
ochratoxin A (OTA) on the growth, feed intake, mortality, blood plasma protein content and some
parameters of lipid peroxidation and the glutathione redox system of pheasant chicks in a three-week
long trial. A total of 320 seven-day-old female pheasants were randomly assigned to four treatment
groups (n5 40 in each), fed with a diet artificially contaminated with OTA [control (<0.02 mg/kg), 0.88
mg/kg, 1.14 mg/kg and 1.51 mg/kg] for 21 days (up to 28 days of age). The pheasant chicks were
sacrificed at early (12, 24 and 72 h) and late (7, 14 and 21 days) stages of mycotoxin exposure to check
the effect of OTA. Minimal feed refusal was found in the medium- and high-dose toxin groups (–9.8
and –7.9%, respectively), and body weight gain was nearly the same in all groups. The glutathione redox
system was activated mainly in the liver, confirmed by significantly increased reduced glutathione
content and glutathione peroxidase activity during the late phase of mycotoxin exposure and at a high-
dose treatment. The results suggest that pheasants have low susceptibility to OTA, and activation of the
glutathione redox system has importance in this tolerance.
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INTRODUCTION
Ochratoxins are worldwide occurring mycotoxins primarily produced by the mould species
Aspergillus ochraceus and Penicillium verrucosum (Gupta, 2007). These toxins contaminate
different grains, such as barley, corn, wheat, and oat (Rafai et al., 2000). Global occurrence
data reported from the last decade show that the incidences and maximum levels in cereal
grains were 29% and 1,164 mg/kg, respectively, for ochratoxin A (OTA) (Lee and Ryu, 2017).
Besides its nephrotoxic properties, ochratoxin displays immunotoxicity (Al-Anati and
Petzinger, 2006), and it is a potent inhibitor of protein synthesis (Niaz et al., 2020). Due to its
long half-life, OTA also can accumulate in the food chain (Gupta, 2007).
The adverse effects of OTA are well recognised in poultry species. The general signs of
ochratoxicosis in poultry species are feed refusal, decreased feed intake, weight gain and egg
production, and increased water intake (Jand et al., 2005). Hamilton et al. (1982) reported the
first ochratoxicosis field outbreak in turkeys, broiler chickens, and laying hens. The myco-
toxin levels of the different feeds in that study varied between 0.3 and 16 mg/kg. In the most
severely affected Turkey flock, total mortality reached 59% by marketing age, and the
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surviving birds expressed feed refusal, poor feed conversion,
and growth rate. In laying hens, 0.3–4 mg/kg of OTA
decreased egg production by 10–15%, and the changes in
eggshell quality were described as ‘thin shell and rubbery shell.’
On the other hand, in broiler chickens, 0.4–2 mg/kg of
OTA caused impaired feed conversion ratio and decreased
growth rate. At higher toxin levels, body weight depression
could become extremely severe. Huff et al. (1975) found
extremely severe (–75%) body weight depression in broilers
after feeding 8 mg/kg dietary ochratoxin for four weeks.
Adverse effects of OTA intake can be observed also at lower
toxin levels. Degeneration and atrophy of the lymphoid organs
were found when chicks were consuming a feed containing
2–5 mg/kg OTA (Stoev et al., 2002; Kumar et al., 2004), and
1 mg/kg caused severe immunosuppression as well as hae-
matological and biochemical disturbances in laying hens
(Sawale et al., 2009). Microscopic lesions in the liver and kidney
were observed at dietary toxin levels as low as 0.16–0.33 mg/kg,
and moderate histological lesions were found when the
experimental diet contained OTA at the limit level recom-
mended by the EU (0.1 mg/kg) for poultry (Pozzo et al., 2013).
The susceptibility of game birds to OTA is varies widely
by species. Feeding 4 mg/kg dietary OTA for three weeks
resulted in a 21% decrease of body weight and 10% higher
mortality in chukar partridges (Ruff et al., 1992). Japanese
and Bobwhite quail possibly have higher OTA tolerance as
the same toxin level (4 mg/kg) did not cause body weight
depression or increased mortality in either species (Ruff
et al., 1990). Pheasants, on the other hand, showed a slight
increase (2.5%) in mortality, but growth performance was
unaffected by the same contamination level (4 mg/kg) of
OTA (Huff et al., 1992). According to these results, the
pheasant seems to be slightly less susceptible to OTA than
the chukar partridge but somewhat more susceptible than
the Bobwhite and Japanese quail.
One of the possible causes of OTA toxicity is the for-
mation of oxygen free radicals, which initiate the peroxi-
dation of polyunsaturated fatty acids (Schaaf et al., 2002).
The mechanisms of response to oxidative stress are
conserved in vertebrates, even in poultry, and this is partly
based on the antioxidant defence, including the glutathione
redox system (Surai et al., 2019). OTA-induced oxidative
stress affects the enzymatic (glutathione peroxidases) and
the non-enzymatic (reduced glutathione) part of the gluta-
thione redox system (Cavin et al., 2007).
The effect of OTA on the glutathione redox system on
lipid peroxidation parameters, reduced glutathione (GSH)
concentration, and glutathione-peroxidase (GPx) activity
has been investigated previously in the course of a three-
week OTA exposure (0.11, 0.65, and 1.13 mg/kg feed) in
broiler chickens (K€ovesi et al., 2019). The results of that
study revealed that, as an effect of OTA, malondialdehyde
(MDA) and reduced glutathione content increased in the
liver and kidney, but not in the blood plasma, and this effect
was more marked in the liver. Glutathione peroxidase ac-
tivity did not change in the blood, a tendency of increase was
found in the liver, but a significant increase was demon-
strated in the kidney. The purpose of the present study was
to investigate the effect of short- and long-term OTA
exposure on some parameters of lipid peroxidation and the
glutathione redox system in pheasants.
MATERIALS AND METHODS
Experimental birds and diet
A total of 320 one-day-old female pheasants (21.86 ± 2.15 g)
were purchased from a hatchery (Perjesi es Tarsa Ltd., Kecel,
Hungary) and transported to the experimental facility of the
Department of Nutrition, Szent Istvan University (G€od€oll}o,
Hungary). Birds were housed in rounded wall pens of 1m
diameter (n 5 40 per pen) with infrared heat lamps
throughout the experimental period (the power and the
height of the lamps were adjusted to the birds’ re-
quirements), and the room temperature was 25 8C. Feeding
was based on a commercial pheasant diet (Table 1). During
the experiment, feed and drinking water were provided ad
libitum.
The experiments were carried out according to the Na-
tional Animal Welfare Act regulations, which are in line
with the relevant EU rules. The experimental protocol was
authorised by the National Food Chain Safety Office (PE/
EA/1965-7/2017).
Mycotoxin production and experimental contamination
of diet
The experimental diet was artificially contaminated with
ochratoxin A, produced on ground corn substrate under
controlled laboratory conditions with an Aspergillus alber-
tensis strain (SZMC 22107) deposited in the Microbiological
Collection of the University of Szeged.
The final concentration of OTA in the milled corn (1 kg)
was 1,067 ± 30.12 mg/kg, measured in five sub-samples (20
g each) in triplicates by the HPLC method with fluorescence
detection after immunoaffinity clean-up with OchraStar R
IAC column (Romer Labs, Tulln, Austria) according to a
standard method (ISO 15141, 2018). The analyses were
carried out by Wessling Hungary Ltd. (Budapest, Hungary)
Table 1. Chemical composition of the pheasant feed











Vitamin A (IU/kg) 12,938
Vitamin D3 (IU/kg) 4,106
Vitamin E (mg/kg) 45.00
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using an HPLC series 1,100 from Agilent Technologies
(Santa Clara, CA, USA). The OTA standard was obtained
from Sigma-Aldrich (St Louis, MI, USA) and was dissolved
in methanol at a 1 mg/mL concentration. Ultraviolet spec-
trophotometry at 333 nm (Hitachi H-2900, Hitachi, Tokyo,
Japan) was used to determine the final concentration in this
OTA solution. All solutions were stored at –20 8C until use.
The target OTA concentrations of the experimental diets
were 0.5, 1 and 2 mg/kg, as multiple doses of limit values
proposed by the EU for broiler chicken diets (0.1 mg/kg).
Based on the final toxin concentration in the growing me-
dium, an appropriate amount of milled corn was mixed with
the basal diet for each experimental group. The OTA con-
tent of the feed was determined in five feed samples (20 g of
each) in triplicates by the high-performance liquid chro-
matography method with fluorescence detection (HPLC-
FLD) as mentioned above. The measured ochratoxin A
content of the feeds are shown in Table 2.
Experimental design
A total of 320 one-day-old female pheasants were randomly
assigned to four groups with different concentrations of
ochratoxin A: control (<0.02 mg OTA/kg), low dose (0.88
mg OTA/kg), medium dose (1.14 mg OTA/kg), and high
dose (1.51 mg OTA/kg) with two replicates of each group (8
pens with 40 birds in each pen). In the first week, birds were
allowed to adapt to the environment. During this period, all
groups received a control feed (Table 1). The treatment was
started with one-week-old birds and lasted for 21 days, up to
28 days of age. Feed consumption, which was determined by
the daily feed intake per pen, and mortality were recorded
daily. The daily portion of pheasant feed in each pen was
calculated according to the results of our previous study
(Fernye et al., 2018). Live body weight was measured before
the birds were sacrificed. The feed conversion ratio (FCR)
was calculated for each group based on the average daily
weight gain and the overall feed intake. For the investigation
of both short- and long-term effects of OTA, six randomly
selected birds from both replicates of each experimental
group were sacrificed at the early (12th, 24th and 72nd h)
and the late (days 7, 14 and 21) stages from the start of the
experiment. The animals were euthanised by cervical dislo-
cation and exsanguination. After extermination, postmor-
tem blood, liver and kidney samples were taken. Blood
samples were taken into heparinised tubes and centrifuged
at 2,300 3 g for 10 min to isolate plasma. Red blood cell
(RBC) haemolysate was also prepared by adding a 9-fold
volume of redistilled water, freezing, and thawing. The
whole liver was taken and weighed, and the lower third of
the large lobe was dissected and packed for further analyses.
Kidneys from both sides were also taken and used for further
analysis. All the samples were stored at –70 8C for further
analysis. Liver and kidney samples (0.1 g) were homogenised
in a nine-fold volume (0.9 mL) of physiological saline (0.9%
w/v NaCl solution).
Lipid peroxidation
In the liver homogenate, conjugated dienes (CD) and con-
jugated trienes (CT) were determined as initial markers of
lipid peroxidation (AOAC, 1984). As a marker of the ter-
minal phase of lipid peroxidation, malondialdehyde con-
centration was measured in the blood plasma and the red
blood cell haemolysate according to Placer et al. (1966) and
in the liver and kidney homogenate based on the method of
Botsoglou et al. (1994) using 1,1,3,3-tetraethoxypropane
(Fluka, Buchs, Switzerland) as standard.
Antioxidant system
Some glutathione redox system parameters were investigated
to study the changes in the antioxidant system. Reduced
glutathione content (Rahman et al., 2006) and glutathione
peroxidase activity (Lawrence and Burk, 1978) were
measured in the blood plasma, red blood cell haemolysate,
and the GSH content and GPx activity of the 10,000 g su-
pernatant fraction of liver and kidney homogenates were
calculated to protein content, which was determined by
biuret reaction (Weichselbaum, 1948) in the blood plasma
and the RBC haemolysate, and in the 10,000 g supernatant




Low dose 0.5 0.88
Medium dose 1 1.14
High dose 2 1.51
Table 3. Effect of ochratoxin A exposure on the calculated feed conversion ratio and mortality through the experiment in pheasants
Experimental group
Feed conversion ratio [feed consumed (g)/weight gained (g)]
Week 0 Week 1 Week 2 Week 3 Total mortality (%) Time of mortality
Control –
(n 5 80)
2.12 (n 5 44) 2.41 (n 5 32) 2.36 (n 5 20) 0 (n 5 0) –
0.88 mg/kg –
(n 5 80)
2.94 (n 5 44) 2.41 (n 5 32) 2.78 (n 5 19) 1.25 (n 5 1) Day 15
1.14 mg/kg –
(n 5 80)
1.83 (n 5 43) 2.49 (n 5 30) 2.34 (n 5 18) 2.50 (n 5 2) Day 4, Day 9
1.51 mg/kg –
(n 5 80)
2.61 (n 5 43) 2.28 (n 5 30) 2.39 (n 5 18) 2.50 (n 5 2) Day 3, Day 7
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fraction of liver and kidney homogenates by Folin phenol
reagent (Lowry et al., 1951).
Statistical analysis
Statistical analysis of the data was carried out using
GraphPad InStat 3.05 software (GraphPad Software, San
Diego, CA, USA). At first the Kolmogorov–Smirnov
normality test was done and, based on the results, either
parametric one-way analysis of variance (with Tukey’s post-
hoc test) or the non-parametric Kruskal–Wallis test (with
Dunn’s post-hoc test) was carried out.
RESULTS
Clinical signs of toxicity and mortality
In the control group, no mortality was observed. The highest
mortality rate (2.50%) was found in the 1.14 mg/kg and 1.51
mg/kg OTA dose groups; however, this value was slightly
higher than in the 0.88 mg/kg dose group (1.25%) (Table 3).
No clinical signs of toxicity were found in the birds, and not
even morbidity signs were observed before death.
Feed intake, body weight and feed conversion ratio
Feed refusal was observed only in the medium- and high-
dose toxin groups (–9.8 and –7.9%, respectively). The birds
of the low-dose group consumed 9.2% more feed than the
control birds. During the trial, body weights were similar in
all four experimental groups; however, the final average
body weights in the low-, medium- and high-dose groups
were lower by 6.3, 8.6 and 7.8%, respectively, than in the
control group. The feed conversion ratio (FCR) was the
lowest in the medium-dose group (Table 3), while the
highest was calculated for the low-dose group (2.94 kg/kg).
In the second and third weeks, the values evened up, and a
slightly higher FCR value was found in the low-dose group
(2.78 kg/kg) in the third week (Table 3). Absolute and
relative (g/100 g body weight) liver weight did not differ
among the experimental groups during the entire study
period (data not shown).
Protein content of the blood plasma
The protein content of the blood plasma eventually
decreased as a result of dietary OTA exposure (Table 4).
There was no significant difference up to 72 h of treatment,
Table 4. Effect of ochratoxin A exposure on protein, malondialdehyde (MDA) and reduced glutathione (GSH) concentrations and
glutathione peroxidase (GPx) activity in the blood plasma of pheasants
Time of exposure Control Low dose (0.88 mg/kg) Medium dose (1.14 mg/kg) High dose (1.51 mg/kg)
Protein (g/L)
12 hours 30.91a ± 7.08 29.14a ± 4.71 31.39a ± 5.22 26.50a ± 4.94
24 hours 33.16a ± 5.34 26.03a ± 6.70 31.48a ± 4.55 29.56a ± 7.33
72 hours 29.55ab ± 5.72 25.79a ± 2.51 32.24b ± 1.76 26.54a ± 3.83
7 days 30.54a ± 6.45 27.57ab ± 4.08 34.16a ± 4.41 24.03b ± 3.39
14 daysy 32.42a ± 2.11 31.19ab ± 3.07 31.98a ± 3.93 26.59b ± 4.27
21 days 34.41a ± 4.70 28.47b ± 3.27 33.46a ± 3.11 25.38b ± 4.68
MDA (mmol/L)
12 hours 6.26a ± 1.81 5.89a ± 1.51 7.23a ± 1.39 6.48a ± 0.67
24 hours 5.73a ± 0.86 4.93a ± 1.51 5.65a ± 1.37 5.22a ± 1.26
72 hoursy 4.80ab ± 1.09 4.16a ± 1.02 5.41ab ± 1.28 6.53b ± 2.14
7 days 4.32a ± 0.58 3.69b ± 0.43 3.94ab ± 0.41 3.00c ± 0.36
14 days 4.73a ± 0.59 4.11b ± 0.38 4.71a ± 0.49 3.51c ± 0.18
21 days 5.06a ± 0.58 4.38a ± 0.62 6.01b ± 0.71 4.57a ± 1.28
GSH (mmol/g protein content)
12 hours 9.57a ± 2.65 9.15a ± 1.24 8.85a ± 2.18 8.31a ± 1.14
24 hours 8.32a ± 1.32 10.65a ± 3.04 10.14a ± 3.50 10.35a ± 3.74
72 hours 8.94a ± 1.87 8.93a ± 0.98 8.60a ± 0.30 9.09a ± 1.33
7 days 10.91a ± 1.73 11.17a ± 1.25 10.59a ± 1.49 14.31b ± 2.50
14 days 9.15ab ± 0.52 8.29a ± 0.68 9.77ab ± 1.19 10.46b ± 1.87
21 days 8.85a ± 1.19 9.57ab ± 1.35 9.32a ± 0.79 11.24b ± 2.47
GPx (U/g protein content)
12 hours 6.93a ± 2.29 6.47a ± 1.01 5.20a ± 2.37 6.08a ± 2.03
24 hours 6.21a ± 0.94 7.91a ± 2.63 6.61a ± 3.34 6.65a ± 1.52
72 hours 8.26a ± 1.73 9.45a ± 2.26 9.53a ± 0.92 12.36b ± 2.28
7 days 8.89a ± 0.81 10.03ab ± 1.95 8.45a ± 1.30 11.58b ± 2.30
14 daysy 8.09a ± 1.47 8.69ab ± 1.15 8.79ab ± 0.51 10.48b ± 2.08
21 days 6.25a ± 1.51 7.94ab ± 1.12 6.08a ± 0.91 8.59b ± 1.69
The values represent the mean ± SD (n 5 12).
a,b Means designated with different superscripts within rows mean significant (P < 0.05) difference between experimental groups calculated
by one-way ANOVA with Tukey's post-hoc test.
y Significant differences were calculated by Kruskal–Wallis test using Dunn's post-hoc test.
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but a significantly (P < 0.05) higher blood plasma protein
content was found in the medium-dose group as compared
to the low- and high-dose groups at 72 h. After one week of
OTA exposure, significantly (P < 0.05) lower protein level
was found in the high-dose group as compared to the
control and the medium-dose groups. This difference
remained significant until the end of the experiment. In the
third week, significantly (P < 0.05) lower protein level was
found in the high- and the low-dose groups as compared to
the control.
Lipid peroxidation parameters
No significant (P > 0.05) change was found in the MDA
levels of the blood plasma in the first 24 h (Table 4). After 72
h, the MDA values showed a significant (P < 0.05) difference
between the low- and high-dose groups. This tendency
changed entirely after one week of exposure as the lowest
MDA level was found in the high-dose group followed by
the low- and medium-dose and in the control groups. After
one and two weeks of OTA exposure the MDA levels was
significantly higher (P < 0.05) in the high- and low-dose
groups compared to the control. In the third week, the
difference was significant (P < 0.05) between the medium-
dose and control groups. No changes were observed in the
MDA content of red blood cell haemolysate (data not
shown). The markers of the initial phase of lipid peroxida-
tion (CD and CT) changed significantly (P < 0.05) only in
the early stages of the experiment, in the liver (Table 6).
After 24 h of exposure, both CD and CT levels decreased
significantly (P < 0.05) in the medium-dose group compared
to the control and the low-dose groups (Table 6). Besides,
the CT level was significantly (P < 0.05) lower in the me-
dium-dose group than in the control and the low-dose
groups at 24 h. MDA level in the high-dose group differed
significantly at the 72-h sampling, when it was significantly
(P < 0.05) lower as compared to the low-dose group. After
three weeks of exposure, MDA levels in the medium- and
high-dose groups were significantly (P < 0.05) lower as
compared to the control (Table 6). Changes in MDA showed
a similar pattern in the kidney as in the liver (Table 8). At
the 72-h sampling, the MDA levels of both the low- and the
high-dose groups were significantly (P < 0.05) lower than
those of the control and the medium-dose groups. After one
week, the MDA level in the high-dose group was signifi-
cantly (P < 0.05) lower than in the control and the low-dose
groups. No other statistically significant difference (P > 0.05)
was found.
Reduced glutathione content
No significant difference (P > 0.05) was found in GSH levels
of the blood plasma in the first 72 h. From the first week of
OTA exposure, an increasing tendency in GSH levels to-
wards the higher toxin levels could be observed (Table 4). In
the first and third weeks of the study, significantly (P < 0.05)
higher GSH levels were found in the high toxin group than
in the control. A significant difference (P < 0.05) was only
found between the high- and low-dose groups in the second
week. In the red blood cell haemolysate, significant changes
(P < 0.05) in GSH concentrations were mostly limited to the
later stages of the experiment (Table 5), even though GSH
levels dropped in the medium-dose group after 12 h of
exposure, which was significant (P < 0.05) as compared to
the control and the high-dose groups. After that, there was
no significant (P > 0.05) change until the second week. In the
second and third weeks, a very similar tendency of GSH
levels was seen as in blood plasma. The highest GSH con-
centrations were measured in the high-dose group while the
lowest levels in the control one; the difference was significant
(P < 0.05) at both sampling times. Changes in the GSH levels
in liver homogenates were seen throughout the experiment.
Table 5. Effect of ochratoxin A exposure on malondialdehyde (MDA) and reduced glutathione (GSH) concentrations and glutathione
peroxidase (GPx) activity of the red blood cell haemolysate of pheasants
Time of exposure Control Low dose (0.88 mg/kg) Medium dose (1.14 mg/kg) High dose (1.51 mg/kg)
GSH (mmol/g protein content)
12 hours 15.40a ± 2.44 13.26ab ± 3.06 12.27b ± 1.51 15.50a ± 3.42
24 hours 9.42a ± 2.48 9.94a ± 1.71 11.17a ± 2.62 10.43a ± 1.98
72 hours 9.84a ± 2.16 13.60a ± 3.24 11.19a ± 3.19 13.03a ± 5.11
7 days 8.95a ± 1.94 8.38a ± 1.85 8.36a ± 1.13 8.85a ± 1.55
14 days 9.63a ± 1.35 11.39ab ± 1.09 10.21a ± 1.05 12.99b ± 2.49
21 days y 10.33a ± 1.73 12.39ab ± 3.50 10.89ab ± 2.07 13.19b ± 1.60
GPx (U/g protein content)
12 hours 4.88ab ± 1.24 4.88ab ± 1.41 4.16a ± 0.56 5.88b ± 1.63
24 hours 6.01ab ± 1.94 5.55a ± 1.59 7.49b ± 2.07 5.83ab ± 1.25
72 hours 8.04a ± 1.58 10.62a ± 5.19 8.72a ± 2.93 9.26a ± 4.04
7 days 6.22a ± 2.31 6.05a ± 1.30 4.87a ± 0.59 5.64a ± 1.50
14 days 5.90ab ± 0.61 6.23bc ± 0.64 5.33a ± 0.63 6.84c ± 032
21 days 5.35a ± 2.17 5.71a ± 1.64 4.44a ± 0.97 4.74a ± 0.86
The values represent the mean ± SD (n 5 12).
a,b Means designated with different superscripts within rows mean significant (P < 0.05) difference between experimental groups calculated
by one-way ANOVA with Tukey's post-hoc test).
y Significant differences were calculated by the Kruskal–Wallis test using Dunn's post-hoc test.
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In the earliest stage (at 12 h) the GSH level in the high-dose
group was significantly (P < 0.05) lower than in the control
and the low-dose groups (Table 7). In the next 12 h, this
tendency changed completely as the highest GSH concen-
tration was measured in the high-dose group, while, the
lowest level was found in the control group, and the dif-
ference was significant (P < 0.05). The same tendency
continued in the late stages of the experiment. After one
week of exposure, the GSH level of the high-dose group was
significantly (P < 0.05) higher compared not only to the
control but also to the low- and medium-dose groups. The
same results were found in the second week, even though
the GSH level of the medium-dose group was significantly
(P < 0.05) higher compared to the control. In the last week,
both the high- and the medium-dose groups had signifi-
cantly higher values than the control and the low-dose
groups. No significant change was found regarding the GSH
levels in the kidney homogenates (data not shown).
Table 6. Effect of ochratoxin A exposure on conjugated diene (CD), conjugated triene (CT), and malondialdehyde (MDA) levels in the liver
homogenate of pheasants
Time of exposure Control Low dose (0.88 mg/kg) Medium dose (1.14 mg/kg) High dose (1.51 mg/kg)
CD (OD 232 nm)
12 hours 0.252a ± 0.074 0.286a ± 0.055 0.278a ± 0.027 0.275a ± 0.033
24 hours 0.377a ± 0.050 0.398a ± 0.126 0.245b ± 0.084 0.297ab ± 0.074
72 hours 0.288a ± 0.014 0.302a ± 0.026 0.286a ± 0.017 0.292a ± 0.018
7 days 0.249a ± 0.059 0.216a ± 0.060 0.226a ± 0.063 0.235a ± 0.060
14 days 0.281a ± 0.025 0.276a ± 0.021 0.280a ± 0.020 0.276a ± 0.019
21 days 0.276a ± 0.017 0.292a ± 0.022 0.276a ± 0.019 0.287a ± 0.021
CT (OD 268 nm)
12 hours 0.147a ± 0.018 0.152a ± 0.023 0.144a ± 0.011 0.147a ± 0.010
24 hours 0.199ab ± 0.048 0.226a ± 0.076 0.141c ± 0.020 0.161bc ± 0.016
72 hours 0.154a ± 0.009 0.164a ± 0.016 0.158a ± 0.008 0.156a ± 0.014
7 days 0.132a ± 0.028 0.119a ± 0.028 0.122a ± 0.030 0.130a ± 0.029
14 days 0.153a ± 0.014 0.150a ± 0.014 0.147a ± 0.014 0.147a ± 0.011
21 days 0.146a ± 0.013 0.158a ± 0.013 0.149a ± 0.012 0.152a ± 0.013
MDA (nmol/g wet weight)
12 hours 32.13a ± 1.33 38.69a ± 7.48 31.73a ± 6.57 37.19a ± 8.00
24 hours 47.78a ± 25.42 39.38a ± 12.93 28.21a ± 7.86 33.41a ± 16.67
72 hours 47.76ab ± 5.75 56.72a ± 8.31 49.98ab ± 2.18 43.50b ± 14.74
7 days 63.22a ± 16.02 56.45a ± 12.67 63.73a ± 14.71 56.06a ± 11.55
14 days 49.85a ± 10.14 42.86a ± 9.01 45.09a ± 10.04 45.26a ± 8.94
21 days 61.35a ± 5.05 52.30ab ± 8.88 45.45b ± 11.86 43.11b ± 10.21
The values represent the mean ± SD (n 5 12).
a,b Means designated with different superscripts within rows mean significant (P < 0.05) difference between experimental groups calculated
by one-way ANOVA with Tukey's post-hoc test.
Table 7. Effect of ochratoxin A exposure on reduced glutathione (GSH) concentration and glutathione peroxidase (GPx) activity in the
10,000 g supernatant of the liver homogenate of pheasants
Time of exposure Control Low dose (0.88 mg/kg) Medium dose (1.14 mg/kg) High dose (1.51 mg/kg)
GSH (mmol/g protein content)
12 hours 3.80ab ± 0.32 3.83a ± 0.18 3.55bc ± 0.23 3.52c ± 0.25
24 hours 3.37a ± 0.90 3.39ab ± 0.97 4.09ab ± 0.33 4.24b ± 0.77
72 hours 3.13a ± 0.50 2.93a ± 0.59 3.34a ± 0.49 3.10a ± 0.45
7 days 2.95a ± 0.93 2.93a ± 0.54 3.40a ± 0.71 4.34b ± 0.58
14 days 2.70a ± 0.32 2.99ab ± 0.45 3.38b ± 0.43 4.91c ± 1.00
21 days 3.27a ± 0.45 2.99a ± 0.42 3.75b ± 0.42 4.15b ± 0.83
GPx (U/g protein content)
12 hours 1.92a ± 0.34 1.71a ± 0.41 1.82a ± 0.36 1.65a ± 0.26
24 hours 1.69a ± 0.80 1.75a ± 0.81 2.20a ± 0.31 2.21a ± 0.52
72 hours 2.42a ± 0.70 2.28a ± 0.64 2.50a ± 0.76 2.09a ± 0.42
7 days 1.99a ± 0.86 1.70a ± 0.72 1.89a ± 0.67 2.77a ± 1.25
14 days 2.15a ± 0.38 2.29a ± 0.63 2.46a ± 0.44 3.37b ± 1.20
21 days 2.56a ± 0.33 2.36a ± 0.42 3.42b ± 0.54 3.72b ± 0.53
The values represent the mean ± SD (n 5 12).
a,b Means designated with different superscripts within rows means significant (P < 0.05) difference between experimental groups calculated
by one-way ANOVA with Tukey's post-hoc test.
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Glutathione peroxidase activity
In the blood plasma, GPx activity followed the changes in
GSH levels during the experiment; however, significant
differences were somewhat more evident (Table 4). As
mentioned before, the same tendency was found, but unlike
in GSH, this could be observed even after 72 h of OTA
exposure. It was significantly (P < 0.05) higher in the high-
dose group than in the control group from the 72nd h of
exposure until the end of the experiment. In the red blood
cell haemolysate, the GPx activity followed the changes in
GSH concentration, too, especially in the early stages of the
trial (Table 5). At the first sampling, GPx activity increased
in the high-dose group; however, the difference was signif-
icant (P < 0.05) only compared to the medium-dose group.
On the other hand, after 24 h of exposure, a significant
difference was found in GPx activity between the medium-
and the low-dose groups. In the same way as for GSH, the
next significant change in GPx activity occurred after two
weeks of OTA exposure. The activity of this enzyme was
found to be increased in the high-dose group, and it was
significantly different only compared to the control and the
medium-dose groups. GPx activity in the liver homogenates
followed the changes of GSH levels through the experiment
(Table 7). In the second week, significantly (P < 0.05) higher
GPx activity was found in the high-dose group than in the
other three groups. In the third week, GPx activity increased
significantly (P < 0.05) in both the medium- and the high-
dose groups as compared to the control and the low-dose
groups. No significant change was found regarding the GPx
activity in kidney homogenates. It changed parallel with the
GSH levels, in the same way as in the liver (data not shown).
DISCUSSION
Feed refusal and body weight depression of poultry resulting
from the consumption of an OTA-contaminated diet have
been described previously (Hoehler and Marquardt, 1996;
Hoehler et al., 1997). These adverse effects were not signif-
icant (P > 0.05) but still observable in the present study.
Moderate feed refusal and weight depression were probably
due to the lower toxin doses used in the present study,
although even the relatively low (0.5–1.0 mg/kg) mycotoxin
levels could negatively influence these parameters (Prior
et al., 1980). Interestingly, Huff et al. (1992) did not find
lower body weights in young pheasants even at higher toxin
levels. Despite the mortality, the results were practically
identical in the medium- and the high-dose groups as in the
1 and 2 mg/kg groups.
The decreased concentration of plasma or serum pro-
teins is considered a valuable indicator of ochratoxicosis
(Huff et al., 1988; Hoehler and Marquardt, 1996; Sakthivelan
and Rao, 2010). The results of the present study support this
effect of OTA in pheasants because blood plasma protein
content decreased significantly. The mechanism of action is
considered to be the inhibition of hepatic protein synthesis
through competitive inhibition of phenylalanyl-t-RNA-
synthetase with phenylalanine (Konrad and R€oschenthaler,
1977; Creppy et al., 1979); however, renal leakage of albumin
caused by kidney lesions is thought to be a possible
contributor (Huff et al., 1988). The inhibitory effect of OTA
on protein synthesis (Niaz et al., 2020) would be the cause of
its immunosuppressive effect due to the depression of
antibody responses and the impaired replacement of im-
mune cells.
Despite the proven pro-oxidant properties of OTA
(Hoehler et al., 1997), MDA concentrations were slightly
lower in tissue samples of the treated groups as compared to
the control. The mechanism behind this could be the acti-
vation of the antioxidant system, such as increased GSH
level and GPx activity. MDA level decreased, which occurred
in the blood plasma and the liver, especially in the latter
stages of the trial, which means that the activation of the
antioxidant response occurred after a longer period of time
in the presence of OTA doses used in this experiment.
The ochratoxin load triggered the antioxidant system of
the pheasants. GSH, the main cellular antioxidant (Dixon
et al., 2014), reacted to the treatment by a significant
elevation in its concentration in almost all tissues, primarily
in the late stages of the trial. Throughout the experiment,
GPx activity changed simultaneously with GSH content in
each tissue, according to the earlier findings (Balogh et al.,
2007). This late response can be explained by the dose- and
time-dependent effects of OTA on the activation of the
redox-sensitive transcription factors. Molecular mechanisms
responding to redox changes, such as oxidative stress, are
conserved in vertebrates, including poultry. The master
Table 8. Effect of ochratoxin A exposure on malondialdehyde (MDA) content of the kidney homogenate of pheasants
Time of exposure Control Low dose (0.88 mg/kg) Medium dose (1.14 mg/kg) High dose (1.51 mg/kg)
MDA (nmol/g wet weight)
12 hours 38.01a ± 11.15 34.90a ± 13.58 49.94a ± 19.03 41.66a ± 9.97
24 hours 54.78a ± 20.39 53.56a ± 16.97 52.54a ± 17.08 42.60a ± 10.26
72 hours 67.20a ± 21.35 42.37b ± 10.00 65.81a ± 13.01 37.78b ± 9.47
7 days 56.42a ± 28.46 51.11a ± 13.71 41.12ab ± 7.82 35.61b ± 7.62
14 days 49.69a ± 6.10 47.99a ± 12.04 56.24a ± 14.26 47.54a ± 15.12
21 days 50.40a ± 16.85 43.22a ± 11.95 48.51a ± 8.05 39.47a ± 11.79
The values represent the mean ± SD (n 5 12).
a,b Means designated with different superscripts within rows means significant (P < 0.05) difference between experimental groups
determined by one-way ANOVA with Tukey's post-hoc test.
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regulator of this response is the transcription factor nuclear
factor-erythroid 2 p45-related factor 2 (Nrf2) in connection
with the Kelch-like ECH-associated protein 1 (Keap1)
(Kensler et al., 2007; Suzuki and Yamamoto, 2015). OTA-
induced oxidative stress has an effect on both enzymatic and
non-enzymatic antioxidant defences (Cavin et al., 2007), and
also modulates Nrf2 gene and protein expression, which
regulates the expression of the Antioxidant Response
Element (ARE) gene cluster (Boesch-Saadatmandi et al.,
2009). Nrf2 induces the expression of genes encoding the
antioxidant system, such as the enzymes of the glutathione
redox pathway, but most of them are inhibited by OTA in
chicken (Zeferino et al., 2016). However, no data are avail-
able on that in pheasant.
Considering the biochemical parameters, the kidney was
the least informative tissue; however, tendencies were similar
as in the liver or blood samples. K€ovesi et al. (2019) used
similar OTA doses in a three-week broiler chicken experi-
ment and could only find significant changes in MDA
content in the one-week sampling period. Of course, these
results do not mean that the kidney was not affected by
ochratoxin A, but possibly the doses used in the present
study did not activate the Keap1-Nrf2-ARE pathway in the
kidney during the early period of exposure but only at later
stages.
It can be concluded that pheasants could tolerate both
short- and long-term OTA exposure as only minor negative
changes were found in the performance traits. Also, pheas-
ants maintained the glutathione redox system on a high
level, which contributed to OTA tolerance.
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